Viral RNAs detected in virions of porcine adenovirus type 3  by Xing, Li & Tikoo, Suresh Kumar
www.elsevier.com/locate/yviro
Virology 321 (2004) 372–382Viral RNAs detected in virions of porcine adenovirus type 3
$
Li Xing and Suresh Kumar Tikoo*
Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E3Received 24 October 2003; returned to author for revision 29 December 2003; accepted 29 December 2003Abstract
It has been demonstrated that cellular and viral RNAs were packaged in the virions of human cytomegalovirus (CMV) and herpes simplex
virus 1 (HSV 1), members of the Herpesviridae family, both of which are enveloped double-stranded DNAviruses. Here, we provide evidence
suggesting that RNAs are packaged in the virions of porcine adenovirus type 3 (PAdV-3), which is a member of the Adenoviridae family, a
non-enveloped double-stranded DNA virus. The RNAs packaged in PAdV-3 virions were enriched in the size range of 300–1000 bases long.
By reverse transcription (RT) of RNAs isolated from purified PAdV-3 virions, PCR amplification, and DNA sequence analysis of PCR
products, we determined the identities of some viral RNAs contained in PAdV-3 virions. The results indicated that the RNAs representing
transcripts from E1A, E1B, DNA binding protein (DBP), DNA polymerase (POL), E4 and some of the late genes including pIIIA, pIII, pV,
Hexon, 33 K, and fiber were detected from purified PAdV-3 virions. In contrast, we could not detect the RNAs representing transcripts of
precursor terminal protein (pTP), 52 kDa, pX, or 100-kDa protein genes in purified virions. Because the transcripts of pIX, IVa2, E3, protease,
pVI, pVII, and pVIII overlap with those of other genes in PAdV-3, we could not definitely conclude that RNAs representing these transcripts
were packaged in virions although the expected DNA fragments were produced by RT-PCR in the RNAs isolated from purified virions.
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The Adenoviridae family is composed of a large group of
DNA viruses termed adenoviruses that infect a wide variety
of mammals and birds (Horwitz, 1990). Over the past
several decades, human adenoviruses have been extensively
studied at the molecular level, and most open reading frames
(ORFs) encoded by the viral genome have been functionally
determined (Russell, 2000). Porcine adenovirus type 3
(PAdV-3), a member of the Mastadenovirus genus, was
isolated from a piglet (Clarke et al., 1967) and shown to
induce transient diarrhea in experimentally infected piglets
(Derbyshire et al., 1975). Recently, determination of the
complete nucleotide sequence and transcriptional map of the
genome have indicated that the genetic organization in
PAdV-3 is collinear to that of human adenoviruses (Reddy
et al., 1998a). Like human adenovirus (HAdV)-5 (Horwitz,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: Tikoo@Sask.Usask.ca (S.K. Tikoo).1990), the genes of PAdV-3 are classified as early (E1, E2,
E3, and E4), intermediate, and late depending on their
kinetics of expression (Reddy et al., 1998a). Molecular
characterization of PAdV-3 has identified several essential
and nonessential regions for replication (Reddy et al.,
1999a, 1999b; Zakhartchouk et al., 2003; Zhou and Tikoo,
2001). In addition, several recombinant PAdV-3s have been
constructed (Reddy et al., 1999a, 1999b; Zakharchouk et al.,
2003) and used for the delivery of vaccine antigens to pigs
(Hammond et al., 2001).
Recently, several laboratories reported that cellular and
viral RNA transcripts were packaged in the virions of both
human cytomegalovirus (HCMV) and herpes simplex virus
1(HSV-1; Brensnahan and Shenk, 2000; Greijer et al.,
2000; Sciortino et al., 2001), both being enveloped DNA
viruses and members of the Herpesviridae family (Roiz-
man, 1990). A HCMV gene array was used to identify a
subset of viral RNA transcripts in purified virions (Brens-
nahan and Shenk, 2000), which upon virus entry were
delivered into infected cells and subsequently translated
into proteins. In addition, using RNA specific nucleic acid
sequence-based amplification (NASBA), HCMV-encoded
RNA transcripts could be detected in cells immediately
after adding UV treated or untreated virus (Greijer et al.,
Fig. 1. Northern blot. PAdV-3-infected VIDO R1 cells grown in the
presence of [3H]-uridine showing 100% CPE were collected and the virions
were purified by CsCl gradient centrifugation. Purified virions were treated
with RNase and then extracted with TRIzol reagent to isolate RNAs. The
RNAs were separated on formaldehyde denaturing agarose gel, transferred
onto hybridization membrane, and then exposed to X-ray film. The
numbers indicating RNA size in bases are shown on the left. Lane 1, RNA
size marker; lane 2, RNAs isolated from purified PAdV-3 virions; lane 3,
RNase-treated RNA isolated from purified PAdV-3 virions.
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cDNA array analysis, viral transcripts could be detected in
purified HSV-1 virions (Sciortino et al., 2001). These
results rekindled our interest in determining if the viral
RNA transcripts were packaged in adenoviral virions as well.
By using PAdV-3 as a model, we provide the evidence
suggesting that PAdV-3 virions contain viral RNA tran-
scripts. With the aid of RT-PCR and DNA sequence analysis,
the identities of some transcripts contained in PAdV-3
virions were determined.Results
Purified PAdV-3 virions contain viral RNAs
To determine if purified PAdV-3 virions contain RNA
transcripts, RNAs synthesized in virus-infected cells were
labeled with [3H]-uridine. The infected cells were collected
and viral particles were released by freezing and thawing,and subsequently purified by double CsCl gradient centri-
fugation. To remove RNAs existing outside or attached to
the surfaces of viral particles, purified virions were treated
with RNase at a concentration of 100 Ag/ml at 37 jC for 3 h.
Finally, viral particles were lysed and then extracted with
TRIzol reagent. The RNA was precipitated with isopropyl
alcohol, centrifuged into a pellet, and then washed several
times with 75% ethanol to remove the free radioactive
uridine. The labeled RNAs were separated by agarose gel
followed by transfer onto a hybridization membrane. After
exposure to X-ray film, the autoradiogram was developed.
As seen in Fig. 1, we detected RNAs in the size range of
between 9000 bases and about 300 bases long (lane 2).
Interestingly, strong signals were observed between 300 and
1000 bases. No such RNAs could be detected after treat-
ment of the RNA sample (isolated from the purified PAdV-3
virions using Trizol reagent) with RNase (lane 3). These
results suggested that the RNase-treated purified virions
contained RNAs.
To confirm the above results and determine the origin of
RNase-resistant PAdV-3 transcripts (Fig. 2A), we performed
a Southern hybridization. Purified PAdV-3 genomic DNA
was digested with BamHI/MfeI (Figs. 2B, a), HindIII (Figs.
2B, b), or NotI (Figs. 2B, c) restriction enzymes and analyzed
by Southern hybridization. The [32P]-labeled cDNA probes
were generated using reverse transcriptase, [32P]-dCTP, and
RNAs isolated from purified virions. The results are shown
in Fig. 2C. All five DNA fragments generated by BamHI and
MfeI digestion (Fig. 2C, panel a, lane 1) displayed positive
signals after hybridization (Fig. 2C, panels b and c, lane 1).
In addition, an extra 4.5-kb DNA fragment [indicated by
dotted line in Fig. 2C (panel b, lane 1)] displayed a positive
signal. Based on the relatively lower amounts of the 4.5-kb
DNA fragment (Fig. 2C, panel a, lane 1), we believe that this
band could be due to the star activity of BamHI restriction
endonuclease (George et al., 1980). Five (Fig. 2C, panel c,
lane 2) of seven expected DNA fragments (Fig. 2C, panels a
and b, lane 2) generated by HindIII digestion displayed
positive signals. NotI digestion of the PAdV-3 genome
produced a total of 10 DNA fragments (Fig. 2C, panels a
and c, lane 3). Due to the similarity in size between N2 and
N3, and between N6 and N7, we were not able to clearly
recognize which of them had been detected positively in
Southern hybridization (Fig. 2C, panel c, lane 3). As
expected, none of the lambda DNA fragment (Fig. 2C, panel
a, lane M) was detected in Southern hybridization (Fig. 2C,
panel c, lane M). However, as expected (Fig. 2C, panel b), all
PAdV-3 specific DNA fragments were detected (Fig. 2C,
panel e) in Southern hybridization using [32P]-labeled PAdV-
3 genomic DNA as a probe. In contrast, none of the PAdV-3
DNA fragment could be detected (Fig. 2C, panel d) in
Southern hybridization using [32P]-labeled cDNA probe(s)
generated in the absence of reverse transcriptase from RNAs
isolated from purified virions. As RNAs isolated from
purified PAdV-3 virions had been reverse transcribed into
cDNA probes specifically binding to PAdV-3 genomic
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contained virus-specific RNAs. Interestingly, whereas the
relative intensity of the B4 fragment is stronger than that of
B5 in ethidium bromide-stained agarose gel (Fig. 2C, panela, lane 1), the former, representing the early region 4 (E4) of
the PAdV-3 genome, displayed a relatively weak intensity
compared with that of the latter in Southern blots (Fig. 2C,
panel c, lane 1). In addition, the H5 fragment (Fig. 2C, panel
Table 1
Primers used in PCR amplification
Primer Sense Antisense
h-actin 5V- TGA ACC CTA AGG CCA ACC-3V 5V- GGA TGT CAA CGT CAC ACT TC-3V
rpL35 5V- CCATGGCCAAGATTAAGGCT-3V 5V- GTACAACCGCTCCTTCCGCT-3V
GAPDH 5V- AAGTGGACATTGTCGCCATC-3V 5V- GGAGGCATTGCTGATGATCT-3V
rpS12 5V- AGGAAGGCATTGCTGCTGGA-3V 5V- GCCATAGTCCTTCACCACCA-3V
alpha 1,3 GT 5V- GCACTTACAACAGAGCCGT-3V 5V- GTATGCTGCAGACTCCTTC-3V
E1A 5V- CCG CAA TTG ACA TGG CGA ACA GAC TTC 5V- CGC TGC ATG AGT CAT AG-3V
E1B 5V- CGG GAT CCC TGC TGG AGG CGC GAA-3V 5V- GCG TCG ACT CAC ACC TGC TGA TAG CTA AC-3V
DBP 5V- CTC GCT GTT GAG ATC CA-3V 5V- GAG GAG GAC GAG GCT GAA GAG A-3V
POL 5V- GCA GGT TGA AGC TGA TGT CAT T-3V 5V- CTT CTA CTT CCA CGT TCA G-3V
PTP 5V- GCA GGC TGA GCG CAC TGA TGA T-3V 5V- ACT GCG CTA CAC CGA GGT CAT C-3V
E3 5V- CGG GAT CCA TGA CTG ACG GTC CCC A-3V 5V- GCG GAT CCT GAC GCT ACG AGC GGT T-3V
E4 5V- GAG TCA CCG GCC ATC TT-3V 5V- CAT CAG CAG GTA CAC AC-3V
IVa2 5V- CTT CAC CGT CAC CGA GAC CAC C-3V 5V- GGA GGA GAT GAG GTT GC-3V
pIX 5V- GTG TGG AGG ATG TCT TC-3V 5V- TAG TAG CAG GCA CCG CA-3V
pIIIA 5V- ATG GCG GCG AGC TCT GAA GCT G-3V 5V- TGA AGG CAT TCA GCG CGG CCA G-3V
52K 5V- AGC TCA AGC GAG AGG CCA TGG-3V 5V- TTG ATG GCC GCC ACC TT-3V
pVII 5V- TCG TCT CGC CCA GCA ACA ACT TT-3V 5V- CAC CGC GTT GAC CAC ATC GGC CA-3V
pIII 5V- ATG AGG AGG ATG ATG CCA GCA G-3V 5V- CAC GAT CGC GTT GTT CAT CAG GT-3V
pVI 5V- CAT GGG CAC TTG GAG CGA AAT C-3V 5V- GAG GAG GAG GAG GCA AGA GGT C-3V
pX 5V- ACG ATG CTG ACC TAC CGG TTG C-3V 5V- TTC AAC TTG TTG CGC ACG CTC G-3V
pV 5V- AGA AGG AGG AGA AGG ACG TCA A-3V 5V- GTG TGT GGT TCC TGC CTT CCT CC-3V
Protease 5V- CAG CAC CGA GGA CGA GCT CCG A-3V 5V- AGG AAG AGG AGG CAG AAG AGT C-3V
Hexon 5V- GTC GAT GAT GCC GCA GTG GTC C-3V 5V- TGG TGG TCT CTT CGT CTT CTT C-3V
pVIII 5V- CCG TAC ATG TGG TCT TAT CAG C-3V 5V- GGA GTT CTG CAG CGT CAG GTA-3V
33 K 5V- CAT CCG CAG CAG CAC CAG CAC-3V 5V- GTG TCC TAC CTG GCT GGC TAC-3V
100 K 5V- ATG GAA GAC CAG CAC AGC GCA-3V 5V- GAA GAG GAG GTA GGT GGC CAG G-3V
Fiber 5V- GAC CGA AGA AGC AGA AG-3V 5V- GAT TGT GTC CTC TGT GG-3V
h-actin (GenBank accession # AF054837); rpL35 (GenBank accession # AB055884); GAPDH (GenBank Accession # AF017079); rpS12 (GenBank
Accession # X79417); alpha 1,3 GT (GenBank Accession # L36152). PAdV-3 specific primers (GenBank Accession # AF083132).
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show an obvious positive signal (Fig. 2C, panel c, lane 2).
Identities of viral RNAs packaged in virions
To determine the identities of viral RNAs packaged in
PAdV-3 particles, reverse transcription (RT)-PCR was per-
formed. Initially, the CsCl-purified virions were treated with
DNase I and RNase to remove contaminating DNA or RNA,
respectively. The RNAs extracted from PAdV-3-infected
VIDO R1 cells as well as from double CsCl-purified
PAdV-3 virions were treated with DNase I to remove the
contaminated viral genomic DNA. To confirm the efficiency
of the RT reaction, h-actin cDNA was amplified using h-
actin-specific primers and RNAs isolated from PAdV-3-
infected VIDO R1 cells. To assess the efficacy and speci-
ficity of primer pairs used in this study, RT-PCR wasFig. 2. Southern hybridization analysis of RNAs isolated from purified PAdV
transcriptional map of PAdV-3 and corresponding locations of known viral transc
with arrows. Dotted lines represent the acceptor and donor sites of alternative spli
pairs. (Adapted from reference Reddy et al., 1998a.) (B) Restriction maps of PAdV
respectively. The restriction cleavage sites and DNA fragments generated by re
genomic DNAwas digested with BamHI/MfeI (lane 1), HindIII (lane 2), and NotI
bromide. Lane M, 1 kb plus DNA size marker. The numbers on the left indicate t
transferred onto the hybridization membrane. (c) The fragments shown in a were
cDNA probes generated by reverse transcription of RNAs isolated from purifie
hybridization membrane and probed with [32P]-labeled cDNA probe(s) generated
transcriptase. (e) The fragments shown in a were transferred onto a hybridizationinitially performed with total RNAs isolated from virus-
infected cells. To demonstrate that RNA associated with the
exterior of purified virions is eliminated by the RNase
treatment, RT-PCR was also performed on RNase-treated
virions (undisrupted). Using selected primers (Table 1), RT-
PCR analysis with RNase-treated purified virions did not
detect any RNA, suggesting that no residual PAdV-3 RNA
was associated with RNase-treated purified intact virions.
The results of three independent RT-PCR experiments with
DNase I-treated RNA isolated from disrupted purified
virions are shown in Fig. 3. The identities of the resulting
PCR products were determined by DNA sequence analysis.
E1 region
The E1 region located at the left end of the virus genome
(Fig. 2A) encodes two distinct transcriptional units, E1A and
E1B, that are transcribed independently from different pro--3 virions. (A) Transcriptional map of PAdV-3. Schematic diagram of
ripts. The viral transcripts and their direction of transcription are indicated
cing. rs, Right-forward DNA strand; ls, left-forward DNA strand; bps, base
-3 genome with BamHI/MfeI, HindIII, and NotI were shown as a, b, and c,
striction digestion are indicated. (C) Southern hybridization. (a) PAdV-3
(lane 3), separated by agarose gel electrophoresis and stained with ethidium
he DNA size in base pairs. (b) Schematic view of the viral DNA fragments
transferred onto a hybridization membrane and probed with [32P]-labeled
d PAdV-3 virions. (d) The fragments shown in a were transferred onto a
from RNAs isolated from purified PAdV-3 virions in the absence of reverse
membrane and probed with [32P]-labeled PAdV-3 genomic DNA.
Fig. 3. RT-PCR amplification. RNAs from PAdV-3-infected VIDO R1 cells or purified PAdV-3 virions were isolated and analyzed by RT-PCR as described in
Materials and methods. The transcripts were analyzed by RT-PCR in the presence (RT+) or absence (RT) of reverse transcriptase in RT reaction mixture.
RNA isolated from purified virions (V) or virus infected cells (C). M, 1 kb plus DNA size marker.
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regulated expression of viral genes (Berk et al., 1979; Jones
and Shenk, 1979). Alternative splicing of E1A and E1B
primary transcripts produces four different types of E1A
transcripts and three different types of E1B transcripts
(Reddy et al., 1998b; Fig. 2A). Using E1A-specific primers,
RT-PCR analysis detected three DNA fragments of 0.35,
0.55, and 0.6 kb long in total RNA isolated from virus-
infected cells (Fig. 3). However, RT-PCR analysis of virion
RNA detected three fragments with the size of 0.35, 0.55 and
0.3 kb (Fig. 3; Table 2) and appropriate splice acceptor and
donor sites (Reddy et al., 1998b). Using E1B-specific
primers, RT-PCR analysis detected DNA fragment of iden-
tical size (0.3 kb) in RNA isolated from infected cells and
from purified virions (Fig. 3).
E2 region
The adenoviral E2 (Fig. 2A) gene products are directly
involved in the synthesis of viral DNA and are subdivided
into E2A [DNA binding protein (DBP)] and E2B [precursor
terminal protein (pTP) and DNA polymerase (POL)] (Reddy
et al., 1998a; Russell, 2000). Using DBP-specific primers,
RT-PCR analysis detected a DNA fragment of 0.55 kb in
RNA isolated from infected cells and from purified virions
(Fig. 3). Similarly, using POL-specific primers, RT-PCR
analysis detected a DNA fragment of 0.7 kb in RNA
isolated from infected cells and from purified virions (Fig.
3). Although RT-PCR analysis using pTP-specific primers
detected a 0.6-kb DNA fragment in RNA isolated from
infected cells, no such DNA fragment could be detected in
RNA isolated from purified virions (Fig. 3).
E3 and intermediate region
The E3 region expresses many proteins that facilitate
viral survival by antagonizing the host’s efforts to eliminate
virus-infected cells (Mahr and Gooding, 1999; Wold et al.,
1999). The intermediate region of the adenoviral genome
includes pIX and IVa2. Both act as transcriptional activators
(Lutz et al., 1997; Tribouley et al., 1994) and are essential
for viral DNA packaging (Ghosh-Choudhury et al., 1987;
Zhang et al., 2001). Using E3 specific primers, RT-PCR
analysis identified a DNA fragment of 0.35 kb in RNA
isolated from infected cells and from purified virions (Fig.
3). Using pIX specific primers, RT-PCR analysis detected aTable 2









E1Ab 530 1233 712, 1043 889, 986, 1141
E4c 33667 31253 33462, 33629 31487, 31505
a Numbers indicating the nucleotide position (nt) are relative to the left
terminus of PAdV-3 genome (Reddy et al., 1998a).
b Reddy et al., 1998b.
c Partial list of E4 splice donor and acceptor sites (Li et al., 2003,
unpublished data).DNA fragment of 0.7 kb in RNA isolated from infected
cells and from purified virions (Fig. 3). Similarly, using
IVa2 specific primers, RT-PCR analysis detected a 0.5-kb
DNA fragment in RNA isolated from infected cells and
from purified virions (Fig. 3).
E4 region
The E4 region located at the right end of the virus genome
(Fig. 2A) is involved in regulation of cellular and viral gene
expression, viral DNA replication, and late viral assembly
(Leopard, 1997). Alternate splicing of primary E4 transcript
produces several E4 transcripts (Reddy et al., 1998a; Li et al.,
2003). Using E4-specific primers, RT-PCR analysis detected
three DNA fragments of 0.25, 0.45, and 0.6 kb long in total
RNA isolated from virus-infected cells (Fig. 3). However,
only the 0.45-kb DNA fragment with appropriate splice
acceptor and donor sites (Li et al., 2003, unpublished data)
could be detected in RNA isolated from purified virions (Fig.
3; Table 2).
Late region
The proteins encoded by the adenoviral late region are
mainly structural proteins and are required for the assembly
of virion particles late in the viral life cycle. The different
transcripts produced by alternative splicing of a primary late
transcript are grouped into six families (L1, L2, L3, L4, L5,
and L6) depending upon the usage of polyA signals (Reddy
et al., 1998a). Using pIIIA, pIII, pV, Hexon, 33 K, and fiber
specific primers, RT-PCR analysis detected DNA fragments
of expected lengths in RNA isolated from virus infected cells
and from purified virions (Fig. 3). Moreover, using pVII,
pVI, pVIII, and protease specific primers, RT-PCR analysis
detected DNA fragments of expected length in RNAs
isolated from virus-infected cells and from purified virions
(Fig. 3). However, using 52 K, pX, and 100 K specific
primers, RT-PCR analysis detected DNA fragments of
expected lengths in RNAs isolated from virus infected cells,
but not in RNAs isolated from purified virions (Fig. 3).
RNA–virion mixing experiment
To further confirm that the virus-specific RNAs we
detected were packaged in the virions and did not represent
carryover material bound to the capsids, we performed a
virion–RNA mixing experiment. As shown in Fig. 4A, the
cellular RNAs mixed with purified virions were undetectable
in agarose gel containing ethidium bromide, both before
(lane 2) and after a second CsCl gradient centrifugation
(lanes 3, 4), indicating that the RNAs outside of the virions
had been efficiently degraded by RNase (lanes 2, 4). In
addition, genomic DNA (viral/cellular) detected before (lane
2) but not after second CsCl gradient centrifugation (lane 3)
indicated that contaminating DNA has been efficiently
degraded by DNase I. Moreover, cDNAs for h-actin, glyc-
eraldehydes 3-phosphate dehydrogenase (GAPDH), alpha-
1,3-galactosyltransferase (alpha 1,3 GT), 60S ribosomal
Fig. 4. RNA–virion mixing experiment. (A) RNase treatment of virion–RNA mixture before (lanes 1, 2) and after (lanes 3, 4) a second CsCl gradient
centrifugation. CsCl gradient-purified PAdV-3 virions were mixed with RNAs isolated from VIDO R1 cells (lane 1) and then treated with RNase at 37 jC for 3
h (lane 2). After treating with DNase I, the virions were purified again with CsCl gradient centrifugation (lane 3) and then treated with RNase (lane 4) once
more. Lane 5, RNA size markers. (B) Southern hybridization of BamHI/MfeI-digested PAdV-3 genomic DNA using [32P]-labeled cDNA probes generated by
reverse transcription of RNAs isolated from samples taken from virion band and samples taken immediately above (upper) and below (lower) the virion band
after CsCl gradient centrifugation. (C) RT-PCR was performed as described in legend to Fig. 3. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; alpha 1,3
GT, alpha-1,3-galactosyltransferase; rpL35, 60S ribosomal protein L35; rpS12, ribosomal protein S12.
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were not detected in RT-PCR with RNA isolated from the
second CsCl gradient-purified PAdV-3 virions, although the
E1A and E4 transcripts were still detectable (Fig. 4C).
To get more conclusive results, RNA isolated from
double gradient centrifugation-purified virions were reverse
transcribed in the presence of [32P]-dCTP. Similarly, the
samples taken from above and below the CsCl virion band
were also reverse transcribed in the presence of [32P]-dCTP.
As shown in Fig. 4B, BamHI/MfeI-digested PAdV-3 ge-
nomic DNA could be detected only with the probe synthe-
sized from RNA isolated from the virion band suggesting
the existence of viral RNA transcripts inside the virions.Discussion
As a novel facet of herpesvirus biology, recent studies
have demonstrated the packaging of viral RNAs in cyto-
megalovirus (CMV) and herpes simplex virus (HSV) viri-
ons (Brensnahan and Shenk, 2000; Greijer et al., 2000;
Sciortino et al., 2001). The presence of RNAs in particles ofPAdV-3 demonstrated that RNA packaging in DNA virus
virions is not limited to members of the Herpesviridae
family. Although we did not examine other members of
the Adenoviridae family, we speculated that RNA packag-
ing could represent a common phenomenon in adenoviruses
infecting other mammals and birds.
In this report, we provide evidence suggesting that viral
RNAs are packaged in PAdV-3 virions, a non-enveloped
DNAvirus. Using RT-PCR, the identities of viral RNAs from
most of the transcription units were determined. Although
RNAs representing 11 viral transcripts (E1A, E1B, DBP,
POL, E4, pIII, pIIIA, pV, Hexon, 33 K, and fiber) could be
consistently detected in purified PAdV-3 virions, RNAs
representing four other transcripts [pTP (E2A), 52 K (L1),
pX(L3), and 100 K (L5)] were never detected in purified
PAdV-3 virions. Although RNAs representing transcripts of
E3, IVa2, pIX, pVII, pVI, protease, and pVIII genes could be
detected in purified PAdV-3 virions, their overlap with tran-
scripts from the L5 region, E2B region, E1B region, pIII, pV,
Hexon, and 33 K genes, respectively (Reddy et al., 1998a),
made it difficult to determine their specificity. In contrast,
RNAs representing selected cellular transcripts could not
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sets differ, absence of a signal inRT-PCRmaynot be taken as a
definitive evidence of the absence of the target RNAs.
At present, the functions of packaged RNAs in the viral
life cycle are not well known. The ready-to-use mRNAs
contained in the virions could be released into cells to
express proteins that take over the cellular gene expression
for viral growth upon virus entry into the infected cells
(Brensnahan and Shenk, 2000; Shenk, 2002). Because
transfection of naked genomic DNA into permissive cells
has become a standard procedure for isolating wild-type or
recombinant adenoviruses (Chartier et al., 1996), it appears
that RNAs packaged in virions are not necessary for
initiation of viral gene expression in the newly infected
cell. However, it is possible that the viral proteins expressed
before the start of viral gene transcription may help the
infecting virus begin its life cycle. Sciortino et al. (2002)
reported that mRNAs packaged in HSV-1 particles were
transferred by VP22 protein to uninfected neighboring cells
for expression, thus preparing these host cells to facilitate
viral infection (Sciortino et al., 2002; Shenk, 2002).
Some adenoviruses (Chiocca et al., 1996; Larsson et al.,
1986a, 1986b; Ma and Mathews, 1993, 1996a, 1996b)
encode a subset of distinct RNAs termed virion-associated
(VA) RNAs (Reich et al., 1966), which serve to antagonize
the antiviral action induced by interferon and are required for
controlling protein synthesis (Kitajewski et al., 1986; O’Mal-
ley et al., 1986; Reichel et al., 1985; Schneider et al., 1984;
Siekierka et al., 1985; Svensson and Akusjarvi, 1985;
Thimmappaya et al., 1982). VA RNAs are transcribed by
RNA polymerase III and display a relatively low molecular
weight (Ma and Mathews, 1993, 1996b). Although a short
VA RNA gene (140 bp) was identified in the PAdV-3
genome (Reddy et al., 1998a), the presence of VA RNA in
PAdV-3 has not been confirmed yet. In Northern blots of
RNAs from purified PAdV-3 virions, the strongest signals
were detected below the size of 1000 bases. Because many of
the PAdV-3 mRNAs are longer than 1000 bases, it is possible
that some RNAs packaged in viral particles could have
unknown function. For example, RNAs contained in viral
particles might modulate cellular gene expression upon entry
into the cells through small interfering RNA (siRNA) path-
way (Sharp, 2001) that happens in the cytoplasm of the
human cells (Zeng and Cullen, 2002).
Regarding RNAs contained in HCMVand HSV-1 virions,
the question of where the RNAs are packaged into virions is
under debate (Brensnahan and Shenk, 2002; Greijer et al.,
2000; Sciortino et al., 2001). Herpesvirus virions are 120–
300 nm in diameter and contain a nucleocapsid surrounded
by a tegument and an envelope (Mocarski, 1996; Roizman,
1990) so there is more than one possible packaging location.
In contrast, as adenovirus virions are 65–80 nm in diameter
and contain only a single layer of capsid with no envelope
(Horwitz, 1990), it is certain that the RNAs are packaged in
the capsids. Moreover, the step in the virus assembly process
involving packaging of these RNAs is not clear. In contrastto HSV 1, the selectivity of viral RNA packaging is not
evident with PAdV-3 as most viral RNA transcripts, includ-
ing early, intermediate, and late, were detectable in both
Southern hybridization and RT-PCR analysis. Although it
can be presumed that the viral RNAs were incorporated into
preformed empty capsids in an expected fashion for adeno-
viral genomic DNA packaging, the possibility cannot be
excluded that the RNA packaging occurred simultaneously
with the assembly of the viral capsid or even the by-products
of the viral assembly process. Alternatively, it is also
possible that the viral RNA entry into the virions is due to
the incorporation of transcriptionally active genomic DNA
into the capsid along with nascent transcripts in the form of
RNA–DNA hybrids or triple helical structures or D loop.Materials and methods
Cells and viruses
VIDO R1 cells (Reddy et al., 1999a) were cultured in
Eagle’s minimum essential medium (MEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS). For
growth and purification of virions, VIDO R1 cells grown in
150 cm2 flasks were infected with PAdV-3 (strain 6618) at a
multiplicity of infection (MOI) of 5 plaque-forming units
(PFU) per cell. The cells showing 100% cytopathic effect
(CPE) at 48 h postinfection were harvested and centrifuged
at 2500 rpm for 10 min in a Beckman AccuSpinFR
centrifuge equipped with a fixed rotor (Beckman Coulter,
Inc.). The cell pellet was resuspended in 10 mM Tris–HCl
(pH 8.0) buffer and disrupted by three cycles of freezing and
thawing at 80 and 37 jC, respectively. Cell debris was
removed by centrifugation at 4000 rpm for 10 min. The
supernatant fluids were collected and incubated with RNase
A (Invitrogen) and DNase I at 37 jC for 2 h at concen-
trations of 100 and 20 Ag/ml, respectively. Finally, treated
supernatant was layered onto a CsCl gradient (1.25, 1.35,
and 1.5 g/cm3) in 10 mM Tris–HCl (pH 8.0) and centri-
fuged for 2 h at 35000 rpm per min at 16 jC in a Beckman
L8-55M ultracentrifuge (Beckman Coulter, Inc.) equipped
with a SW41 rotor. The banded virus was collected and
purified again by a second CsCl gradient centrifugation.
Finally, the purified virus band was collected and dialyzed
overnight against 10 mM Tris–HCl. The dialyzed virus was
aliquoted and stored at 80 jC until further use.
RNA labeling
To obtain [3H]-labeled viral and cellular RNA transcripts,
VIDO R1 cells were infected with PAdV-3 at a MOI of 5
PFU per cell. At 12 h postinfection, 0.5 mCi of [3H]-uridine
(Amersham Biosciences) was added in a volume of 10 ml.
After 20–36 h of labeling, the cells showing 100% CPE
were harvested and the virions were purified as described
above.
rology 321 (2004) 372–382Virion–RNA mixing experiment
One milliliter of double CsCl gradient-purified virions
was mixed with 500 Ag total cellular RNA isolated from
VIDO R1 cells. The mixture was incubated at room tem-
perature for 30 min and then at 4 jC for 30 min before
treating with RNase at 37 jC for at least 3 h. The genomic
DNA (cellular/viral) was removed by treatment with DNase
I at a concentration of 20 Ag/ml at 37 jC for 1 h. The
resulting sample was purified once more using CsCl gradi-
ent centrifugation as described above. The virus band was
collected. The purified virions were treated with RNase at
37 jC for at least 3 h and then extracted with TRIzol reagent
to isolate RNAs as described below. At each step of the
experiment, the presence of RNAs outside of the virions
was examined by running samples in agarose gel containing
ethidium bromide (Fig. 4A). Radiolabeled cDNA was
prepared by reverse transcription reaction from RNA iso-
lated from purified virions and used in Southern hybridiza-
tion to detect BamHI/MfeI-digested PAdV-3 genomic DNA.
The purified RNA was also used for RT-PCR as described
below.
Isolation of RNAs from purified virions
The RNAs were extracted from RNase A-treated virions
by using 800 Al of TRIzol reagent according to the manu-
facturer’s instructions (Invitrogen). After washing with 75%
ethanol, the RNAs were dissolved in 20 Al of diethyl
pyrocarbonate (DEPC)-treated water. The contaminating
DNA was removed by using DNA-free DNase treatment
and removal kit according to the manufacturer’s instructions
(Ambion Inc).
RNA blotting
After incubation of samples at 65 jC for 10 min, the
RNAs were loaded into a denaturing 1% agarose–2.2 M
formaldehyde gel. The RNAs were separated by electro-
phoresis for 3 h and blotted onto the Gene Screen Plus
hybridization transfer membrane (Perkin Elmer Life Sci-
ence) according to the instructions of the manufacturer. The
membrane was baked for 2 h at 80 jC in a vacuum oven and
exposed to X-ray film (Kodak) for 6 days.
Preparation of cDNA probes for southern hybridization
The cDNA probes were prepared according to the meth-
ods described previously (Sciortino et al., 2002). Briefly, 10
Ag of total RNAs isolated from purified PAdV-3 virions were
used to generate radioactive cDNAs with the aid of 600 U of
SuperScript II (RNase H) reverse transcriptase (Invitrogen).
The reverse transcription was primed with a mixture of
random hexanucleotides and oligo-dT (12–18 mer) and
performed in the presence of 1 mM dATP, dGTP, dTTP,
and 15 Al of [32P]-dCTP (Amersham Pharmacia) in a total
L. Xing, S.K. Tikoo / Vi380reaction volume of 60 Al. After adding 80 U of anti-RNase
(Ambion Inc.), the reaction mixture was incubated at 42 jC
for 2 h followed by heat inactivation at 100 jC for 5 min. As
a negative control, the same amount of RT reaction mixtures
were prepared without reverse transcriptase. In addition,
PAdV-3 genomic DNA was labeled with [32P]-dCTP using
a DNA polymerase and random primer DNA labeling kit
according to the manufacturer’s instructions (Invitrogen).
Viral genomic DNA preparation and Southern hybridization
Purified PAdV-3 virions were resuspended in extraction
buffer [10 mM Tris–HCl, 0.1 M EDTA, 20 Ag RNase per ml,
0.5% sodium dodecyl sulfate (SDS), pH 8.0] containing
proteinase K at a concentration of 100 Ag/ml (Sambrook et
al., 1989). After incubation at 50 jC for 2 h, phenol and
chloroform extractions were performed (Sambrook et al.,
1989). Viral genomic DNAs were then precipitated by 100%
ethanol. After washing with 70% ethanol, the DNA pellet
was dissolved in TE (10 mM Tris–HCl, 1 mM EDTA, pH
8.0). Viral genomic DNA was digested with BamHI/MfeI,
HindIII, or NotI, and then loaded into 1% agarose gel.
Fractionated DNAs were transferred onto Gene Screen Plus
hybridization transfer membrane (Perkin Elmer Life Sci-
ence) according to the manufacturer’s instructions. The
membrane was baked at 80 jC for 2 h in a vacuum oven,
and then soaked in 2 SSC (1 SSC is 0.15 M NaCl, 0.015
M sodium citrate) for 10 min. Prehybridization was per-
formed in hybridization buffer [ULTRAhyb ultra sensitive
hybridization solution, Ambion Inc.] at 42 jC for 0.5 h and
then [32P]-labeled cDNA probes were added into hybridiza-
tion buffer. After hybridization at 42 jC for 24 h, the
membrane was washed twice with 2 SSC and 0.1% SDS
at room temperature for 5 min each time, and then it was
washed twice with 0.1 SSC and 0.1% SDS at 50 jC for 30
min each time. The dry membrane was exposed to X-ray film
(Kodak).
Isolation of RNAs from virus-infected cells
VIDO R1 cells were infected with PAdV-3 at a MOI of 5
PFU per cell. The cells showing 40% cytopathic effects (36
h postinfection) were collected, lysed using TRIzol RNA
isolation reagent (Invitrogen), and the total RNAs were
isolated according to the manufacturer’s instructions. The
contaminating DNA was removed by using DNA-free
DNase treatment and removal kit according to the manu-
facturer’s instructions (Ambion Inc.).
Reverse transcription (RT)-PCR
Three micrograms of DNase I-treated RNAs extracted
from purified virions or virus-infected cells were reverse
transcribed to yield single-stranded cDNA. The reverse
transcription (RT) was primed with random hexanucleotides
and performed at 42 jC for 2 h in a total volume of 20
L. Xing, S.K. Tikoo / Virology 321 (2004) 372–382 381Al containing 1 mM each of dCTP, dATP, dGTP, and dTTP,
200 U of SuperScript II (RNase H) reverse transcriptase
(Invitrogen), and 20 U of RNase (Ambion Inc.). The RT
reaction was stopped by heating to 100 jC for 5 min. The
cDNAs obtained from reverse transcription of RNAs were
amplified using specific primers (Table 1) by PCR under the
following conditions: 94 jC for 40 s, 45 jC for 40 s, and 72
jC for 50 s. Thirty-five cycles were performed. The PCR
products were loaded into 1.5% agarose gel and visualized
by ethidium bromide staining. Finally, each of the PCR-
amplified DNA fragment was analyzed by DNA sequencing
in both directions using corresponding primers (Table 1).Acknowledgments
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